29,504 Followers on Owler
AbbVie
is an Illinois-based pharmaceutical company that develops and markets medicinal drugs for the treatment of diseases in fields such as neuroscience and oncology...
AbbVie
is an Illinois-based pharmaceutical company that develops and markets medicinal drugs for the treatment of diseases in fields such as neuroscience and oncology...
News
investment
May 21, 2023
https://www.globenewswire.com/news-release/2023/05/22/2673424/0/en/Quanta-Therapeutics-Raises-Over-50-Million-in-Series-D-Financing-to-Advance-its-Pipeline-of-KRAS-Inhibitors.html
Abbvie, Inc. has invested $51M in Quanta Therapeutics, Inc.
Fraud
May 12, 2023
Endpoints News
AbbVie sues Payer Matrix over alleged fraudulent use of patient assistance program
Product Launch
Jan 24, 2023
Hospital Management
Jude Children's Research Hospital launches Family Commons
Partnership
Jan 06, 2023
The Business Journals: Chicago
Immunome enters into a cancer drug collaboration with AbbVie worth up to $2.8B
ESG
Dec 12, 2022
Markets Insider
AbbVie Named to Dow Jones Sustainability World Index for 10th Straight Year
Acquisition
Oct 20, 2022
Seeking Alpha
AbbVie acquired DJS Antibodies Ltd. for $255M
AbbVie Competitors
1
2
3
4
5
6
7
8
9
10
Looking for similar companies to AbbVie?
AbbVie Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$56.7B
AbbVie's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 39.9B. Over the last four quarters, AbbVie's revenue has decreased by 16.2%. Specifically, in Q1 2023's revenue was $12.2B; in Q4 2022, it was $15.1B; in Q3 2022, it was $14.8B; in Q2 2022, AbbVie's revenue was $14.6B.
AbbVie News
AbbVie Press Releases
AbbVie Videos
AbbVie Headquarters
AbbVie Summary
ABOUT
Overview
AbbVie, Inc. (NYSE: ABBV) is engaged in the development, production, manufacture, and sale of pharmaceutical products. It is a research-based pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and chemically-synthesiz...CEO
AbbVie's Chairman & CEO, Richard A. Gonzalez, currently has an approval rating of 76%. AbbVie's primary competitors are Amgen, Novo Nordisk, GSK and 18 more.Website
abbvie.comCompetitors
View 21 AbbVie competitors here.Acquisitions
View 7 companies acquired by AbbVie here.Funding
View AbbVie funding details.Investments
View 15 AbbVie investments here.Frequently Asked Questions about AbbVie
When was AbbVie founded?
AbbVie was founded in 2013Who is AbbVie's CEO?
AbbVie's CEO is Richard A. GonzalezHow much revenue does AbbVie generate?
AbbVie generates $56.7B in revenueHow much funding does AbbVie have?
AbbVie has historically raised $6B in fundingWhere is AbbVie's headquarters?
AbbVie's headquarters is in North Chicago Illinois, USA
How many employees does AbbVie have?
AbbVie has 50,000 employeesWhat sector does AbbVie operate in?
AbbVie is in Biotechnology, PharmaceuticalsWho are AbbVie's competitors?
AbbVie's top competitors are Amgen, Novo Nordisk, GSKWho has AbbVie invested in?
AbbVie's has invested in companies such as Carisma, Quanta Therapeutics, Kojin